Society guideline links: Osteoporosis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately.

●(See "Society guideline links: Healthy diet in adults".)

●(See "Society guideline links: Healthy diet in children and adolescents".)

●(See "Society guideline links: Vitamin D deficiency".)

●(See "Society guideline links: Vitamin deficiencies".)

●(See "Society guideline links: Menopause".)

●(See "Society guideline links: Clinical densitometry".)

●(See "Society guideline links: Medication-related osteonecrosis of the jaw".)

International

●International Osteoporosis Foundation (IOF): Articles and position papers

●North American Menopause Society (NAMS): Position statement on management of osteoporosis in postmenopausal women (2021)

●Endocrine Society (ES): Guideline on pharmacological management of osteoporosis in postmenopausal women, update (2020)

•ES: Clinical practice guideline on the pharmacological management of osteoporosis in postmenopausal women (2019)

●International Society for Clinical Densitometry (ISCD): Official positions – Adult (2019)

●ISCD: Official positions – Pediatric (2019)

●ISCD: Best practices for dual-energy x-ray absorptiometry measurement and reporting (2016)

●NAMS: Recommendations for clinical care of midlife women (2014)

●ES: Clinical practice guideline on osteoporosis in men (2012)

Canada

●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations on screening for primary prevention of fragility fractures (2023)

●Osteoporosis Canada: Clinical practice guideline for management of osteoporosis and fracture prevention in Canada, update (2023)

●Choosing Wisely Canada: Don't order DEXA (Dual-Energy X-ray Absorptiometry) screening for osteoporosis on low risk patients (updated 2022)

●Choosing Wisely Canada: Don't prescribe bisphosphonates for patients at low risk of fracture (updated 2022)

●Choosing Wisely Canada: Don't repeat dual energy X-ray absorptiometry (DEXA) scans more often than every 2 years (updated 2022)

United States

●American Academy of Pediatrics (AAP): Clinical report on bone densitometry in children and adolescents (2016, reaffirmed 2023)

●American College of Obstetricians and Gynecologists (ACOG): Clinical practice guideline for the management of postmenopausal osteoporosis (2022)

●American College of Radiology (ACR): ACR Appropriateness Criteria for management of vertebral compression fractures (2022)

●ACR: ACR Appropriateness Criteria on osteoporosis and bone mineral density (2022)

●American College of Rheumatology (ACR): Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis (2022)

●Bone Health and Osteoporosis Foundation (BHOF): Consensus statement – The clinician's guide to prevention and treatment of osteoporosis (2022)

●ACOG: Clinical practice guideline on osteoporosis prevention, screening, and diagnosis (2021)

●American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE): Clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis, update (2020)

●American Society of Clinical Oncology (ASCO): Clinical practice guideline for the management of osteoporosis in survivors of adult cancers with nonmetastatic disease (2019)

●US Preventive Services Task Force (USPSTF): Final recommendation statement – Osteoporosis to prevent fractures: Screening (2018)

●American College of Physicians (ACP): A clinical practice guideline on treatment of low bone density of osteoporosis to prevent fractures in men and women, update (2017)

●American Society of Bone and Mineral Research (ASBMR): Managing osteoporosis in patients on long-term bisphosphonate treatment – Report (2016)

●AAP: Clinical report on optimizing bone health in children and adolescents (2014)

●ASBMR: Atypical subtrochanteric and diaphyseal femoral fractures – Second report (2014)

●National Bone Health Alliance (NBHA): A position statement on the clinical diagnosis of osteoporosis (2014)

●ASBMR: Making the first fracture the last fracture – Report on secondary fracture prevention (2012)

Europe

●European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and International Osteoporosis Foundation (IOF): Results of an expert group meeting – Update on the clinical use of trabecular bone score in the management of osteoporosis (2023)

●European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS): Position statement on managing the menopause after gynecological cancer – Focus on menopausal symptoms and osteoporosis (2020)

●ESCEO and IOF: European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2019)

●EMAS: Clinical guide on calcium in the prevention of postmenopausal osteoporosis (2018)

●European League Against Rheumatism (EULAR) and European Federation of National Associations of Orthopaedics and Traumatology (EFORT): Recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures (2017)

●EMAS: Position statement on drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis (2017)

●EMAS: Position statement – The management of postmenopausal women with vertebral osteoporotic fracture (2014)

●EMAS: Clinical guide – Selective estrogen receptor modulators for postmenopausal osteoporosis (2012)

●EMAS: Position statement – Bone densitometry screening for osteoporosis (2011)

United Kingdom

●National Osteoporosis Guideline Group (NOGG): Clinical guideline for prevention and treatment of osteoporosis (updated 2021)

●Scottish Intercollegiate Guidelines Network (SIGN): Management of osteoporosis and the prevention of fragility fractures - A national clinical guideline (2015, revised 2021)

●Choosing Wisely UK: British Society of Rheumatology – Recommendation 4: Bisphosphonate therapy should be reviewed with every patient after 3-5 years, and a treatment holiday considered. This should follow a shared-decision making conversation which includes the risks and benefits of continued treatment (2018)

●National Institute for Health and Care Excellence (NICE): Clinical guideline on osteoporosis – Assessing the risk of fragility fracture (2012, updated 2017)

●NICE: Quality standard on osteoporosis (2017)

Australia–New Zealand

●Healthy Bones Australia (HBA): Position statement on the management of osteoporosis, 5th edition (2023)

●Endocrine Society of Australia (ESA), Australian and New Zealand Bone and Mineral Society (ANZBMS), Australasian Menopause Society (AMS) and the Clinical Oncology Society of Australia (COSA): Position statement on assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy (2018)

●Choosing Wisely Australia: Do not discharge patients with osteoporotic fractures without an assessment and/or treatment for osteoporosis (2017)

●Royal Australian College of General Practitioners (RACGP) and Osteoporosis Australia (OA): Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age, 2nd edition (2017)

●ANZBMS: Position paper on secondary fracture prevention (2015)

Japan

●[In English] Japan Osteoporosis Society (JOS): Executive summary of the guide for the use of bone turnover markers in the diagnosis and treatment of osteoporosis (2018 edition) (published 2019)

●[In Japanese] JOS, Japan Society for Bone and Metabolism (JSBM), Japan Osteoporosis Foundation (JOF): Osteoporotic prevention and treatment guidelines (2015)